Back to mobile site

SVB Leerink Downgrades Nightstar Therapeutics (NITE) to Market Perform Following Acquisition

March 5, 2019 12:48 AM EST Send to a Friend
SVB Leerink analyst Joseph Schwartz downgraded Nightstar Therapeutics (NASDAQ: NITE) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login